364 related articles for article (PubMed ID: 17564678)
21. Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility.
Frau L; Simola N; Plumitallo A; Morelli M
J Neurochem; 2013 Jan; 124(1):69-78. PubMed ID: 23083295
[TBL] [Abstract][Full Text] [Related]
22. Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain.
Bull EJ; Porkess V; Rigby M; Hutson PH; Fone KC
J Psychopharmacol; 2006 Mar; 20(2):272-80. PubMed ID: 16510485
[TBL] [Abstract][Full Text] [Related]
23. Lesion of medial prefrontal dopamine terminals abolishes habituation of accumbens shell dopamine responsiveness to taste stimuli.
Bimpisidis Z; De Luca MA; Pisanu A; Di Chiara G
Eur J Neurosci; 2013 Feb; 37(4):613-22. PubMed ID: 23216547
[TBL] [Abstract][Full Text] [Related]
24. Effects of repeated daily treatments with a 5-HT3 receptor antagonist on dopamine neurotransmission and functional activity of 5-HT3 receptors within the nucleus accumbens of Wistar rats.
Liu W; Thielen RJ; McBride WJ
Pharmacol Biochem Behav; 2006 Jun; 84(2):370-7. PubMed ID: 16828150
[TBL] [Abstract][Full Text] [Related]
25. Mice with decreased cerebral dopamine function following a neurotoxic dose of MDMA (3,4-methylenedioxymethamphetamine, "Ecstasy") exhibit increased ethanol consumption and preference.
Izco M; Marchant I; Escobedo I; Peraile I; Delgado M; Higuera-Matas A; Olias O; Ambrosio E; O'Shea E; Colado MI
J Pharmacol Exp Ther; 2007 Sep; 322(3):1003-12. PubMed ID: 17526809
[TBL] [Abstract][Full Text] [Related]
26. 3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex.
Nair SG; Gudelsky GA
Synapse; 2005 Dec; 58(4):229-35. PubMed ID: 16206181
[TBL] [Abstract][Full Text] [Related]
27. Nicotine differentially affects dopamine transmission in the nucleus accumbens shell and core of Lewis and Fischer 344 rats.
Cadoni C; Muto T; Di Chiara G
Neuropharmacology; 2009; 57(5-6):496-501. PubMed ID: 19647004
[TBL] [Abstract][Full Text] [Related]
28. Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices.
Iravani MM; Asari D; Patel J; Wieczorek WJ; Kruk ZL
Synapse; 2000 Jun; 36(4):275-85. PubMed ID: 10819905
[TBL] [Abstract][Full Text] [Related]
29. Neurotoxicity mechanisms of thioether ecstasy metabolites.
Capela JP; Macedo C; Branco PS; Ferreira LM; Lobo AM; Fernandes E; Remião F; Bastos ML; Dirnagl U; Meisel A; Carvalho F
Neuroscience; 2007 Jun; 146(4):1743-57. PubMed ID: 17467183
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pretreated rats.
Acquas E; Tanda G; Di Chiara G
Neuropsychopharmacology; 2002 Aug; 27(2):182-93. PubMed ID: 12093592
[TBL] [Abstract][Full Text] [Related]
31. Acetaldehyde elicits ERK phosphorylation in the rat nucleus accumbens and extended amygdala.
Vinci S; Ibba F; Longoni R; Spina L; Spiga S; Acquas E
Synapse; 2010 Dec; 64(12):916-27. PubMed ID: 20506324
[TBL] [Abstract][Full Text] [Related]
32. Effect of beta-phenylethylamine on extracellular concentrations of dopamine in the nucleus accumbens and prefrontal cortex.
Murata M; Katagiri N; Ishida K; Abe K; Ishikawa M; Utsunomiya I; Hoshi K; Miyamoto K; Taguchi K
Brain Res; 2009 May; 1269():40-6. PubMed ID: 19285043
[TBL] [Abstract][Full Text] [Related]
33. A differential activation of dopamine output in the shell and core of the nucleus accumbens is associated with the motor responses to addictive drugs: a brain dialysis study in Roman high- and low-avoidance rats.
Lecca D; Piras G; Driscoll P; Giorgi O; Corda MG
Neuropharmacology; 2004 Apr; 46(5):688-99. PubMed ID: 14996546
[TBL] [Abstract][Full Text] [Related]
34. Hippocampal dopamine receptors modulate cFos expression in the rat nucleus accumbens evoked by chemical stimulation of the ventral hippocampus.
Zornoza T; Cano-Cebrián MJ; Martínez-García F; Polache A; Granero L
Neuropharmacology; 2005 Dec; 49(7):1067-76. PubMed ID: 16040065
[TBL] [Abstract][Full Text] [Related]
35. A new brain area affected by 3,4-methylenedioxymethamphetamine: A microdialysis-biotelemetry study.
Benamar K; Geller EB; Adler MW
Eur J Pharmacol; 2008 Oct; 596(1-3):84-8. PubMed ID: 18727928
[TBL] [Abstract][Full Text] [Related]
36. The electrophysiological effects of neurotensin on spontaneously active neurons in the nucleus accumbens: an in vivo study.
Stowe ZN; Landry JC; Tang Z; Owens MJ; Kinkead B; Nemeroff CB
Synapse; 2005 Dec; 58(3):165-72. PubMed ID: 16108007
[TBL] [Abstract][Full Text] [Related]
37. CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement.
Touriño C; Ledent C; Maldonado R; Valverde O
Biol Psychiatry; 2008 Jun; 63(11):1030-8. PubMed ID: 17950256
[TBL] [Abstract][Full Text] [Related]
38. Neonatal ventral hippocampal lesions potentiate amphetamine-induced increments in dopamine efflux in the core, but not the shell, of the nucleus accumbens.
Corda MG; Piras G; Giorgi O
Biol Psychiatry; 2006 Dec; 60(11):1188-95. PubMed ID: 16934777
[TBL] [Abstract][Full Text] [Related]
39. Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain.
Baumann MH; Clark RD; Rothman RB
Pharmacol Biochem Behav; 2008 Aug; 90(2):208-17. PubMed ID: 18403002
[TBL] [Abstract][Full Text] [Related]
40. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
Freezer A; Salem A; Irvine RJ
Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
